• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Intrahepatic Cholangiocarcinoma

Intrahepatic Cholangiocarcinoma - 31 Studies Found

Completed : SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma
: Intrahepatic Cholangiocarcinoma
: 2016-05-13
:
  • Drug: Cisplatin-gemcitabine Sy

Completed : Calcitriol in Advanced Intrahepatic Cholangiocarcinoma
: Advanced Intrahepatic Cholangiocarcinoma
: 2009-12-22
: Drug: Calcitriol 12 mcg Calcitriol will be given orally three times per week for 6 months. In this porti
Not yet recruiting : A Trial of Systemic Chemotherapy in Combination With Conventional Transarterial Chemoembolization in Patients With Advanced Intra-Hepatic Cholangiocarcinoma
: Unresectable Intrahepatic Cholangiocarcinoma
: 2016-12-06
:
  • Drug: gemcitabine 1000 mg/m^2

Completed : Drug-Eluting Bead, Irinotecan Therapy for Unresectable Intrahepatic Cholangiocarcinoma w/Concomitant Gemcitabine and Cisplatin or Carboplatin
: Unresectable Intrahepatic Cholangiocarcinoma
: 2012-07-17
:
  • Device: LC or ONCOZENE Bead with Gem-Cis or Gem-Carbo

Completed : Stereotactic Body Radiotherapy for Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma
:
  • Carcinoma, Hepatocellular
  • Intrahepatic Cholangiocarcinoma

  • : 2012-08-08
    : Radiation: Stereotactic radiation
Not yet recruiting : Melphalan for Use With the Hepatic Delivery System Treatment in Patients With Unresectable Hepatocellular Carcinoma or Intra Hepatic Cholangiocarcinoma
:
  • Hepatocellular Carcinoma
  • Intrahepatic Cholangiocarcinoma
  • <
    : 2015-04-08
    :
    • Device: Delcath Hepatic Delivery System

Active, not recruiting : Analysis of Oncogenes in Intrahepatic Cholangiocarcinoma or Mixed Hepatocellular-Cholangiocarcinoma in Tumor Tissue Samples
:
  • Intrahepatic Cholangiocarcinoma
  • Mixed Hepatocellular Cholangioc
    : 2016-05-02
Active, not recruiting : Gemcitabine Hydrochloride and Cisplatin With or Without Radiation Therapy in Treating Patients With Localized Liver Cancer That Cannot Be Removed by Surgery
:
  • Stage III Intrahepatic Cholangiocarcinoma
  • Stage IVA : 2014-07-08
    :
    • Drug: Cisplatin Given IV

Active, not recruiting : Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Gemcitabine as Adjuvant Treatment After Resection of Intrahepatic Cholangiocarcinoma
:
  • Intrahepatic Cholangiocarcinoma
  • Peripheral Cholangiocarcinoma : 2013-09-05
    :
    • Procedure: Liver resection and placement of hepatic artery infusion pump

Completed : Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC)
:
  • Intrahepatic Cholangiocarcinoma
  • Peripheral Cholangiocarcinoma : 2013-05-20
    :
    • Drug: Floxuridine (FUDR)
    • Drug: dexamethaso

<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.